Founding Year

Particle3D uses proprietary technology to 3D print patient specific, natural and resorbable bone implants. This enables fast ingrowth of bone tissue, remodeling into real living bone, and results in fewer complications. The technology can also be used for 3D printed R&D products, implants designed to release additives, such as antibiotics or other drugs, and even in industries outside healthcare.


A company that is newly founded or in the early-growth stage and needs more funding to grow. It accurately states its mission, vision and its sustainability and impact purpose but still has a low level of establishment. The startup has the potential to have a positive impact on a global scale and to generate substantial change for underserved communities or areas. The risk that impact does not occur as expected is medium.


3D printed bone implants and 3D printed R&D products with which we provide a cost-effective method to perform relevant and predictive laboratory tests to study human diseases, cell growth, and test new treatments.

Particle3D has developed a novel technology to reconstruct the patient’s exact anatomy with 3D printed, patient specific implants with bone-like porosity. The implants are made from natural biomaterials which degrade over time and remodel into real living bone tissue.

To allow surgeons to provide bone implants that precisely match patient needs and streamline workflows, thereby improving patient outcomes and procedural efficiency while reducing costs. For patients, this entails low risk of adverse effects, optimal functional and aesthetic outcomes and fast recovery.

Surgeons that perform bone reconstructions and bone augmentations, and patients needing bone repair for example due to congenital bone defects, traumatic injury, or diseases such as cancer.

Sale of medical devices.

Customers, Communities, Investors